A detailed history of Northern Trust Corp transactions in Chimerix Inc stock. As of the latest transaction made, Northern Trust Corp holds 589,300 shares of CMRX stock, worth $571,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
589,300
Previous 558,486 5.52%
Holding current value
$571,621
Previous $591,000 12.35%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.05 $26,808 - $32,354
30,814 Added 5.52%
589,300 $518,000
Q1 2024

May 14, 2024

SELL
$0.91 - $1.26 $119,966 - $166,107
-131,831 Reduced 19.1%
558,486 $591,000
Q4 2023

Feb 13, 2024

SELL
$0.9 - $1.06 $34,223 - $40,307
-38,026 Reduced 5.22%
690,317 $662,000
Q3 2023

Nov 13, 2023

SELL
$0.94 - $1.23 $1,222 - $1,600
-1,301 Reduced 0.18%
728,343 $699,000
Q2 2023

Aug 11, 2023

BUY
$1.1 - $1.54 $2,176 - $3,047
1,979 Added 0.27%
729,644 $882,000
Q1 2023

May 15, 2023

BUY
$1.19 - $2.09 $24,179 - $42,466
20,319 Added 2.87%
727,665 $916,000
Q4 2022

Feb 13, 2023

SELL
$1.67 - $2.35 $136,038 - $191,431
-81,460 Reduced 10.33%
707,346 $1.32 Million
Q3 2022

Nov 14, 2022

BUY
$1.81 - $2.76 $51,295 - $78,218
28,340 Added 3.73%
788,806 $1.52 Million
Q2 2022

Aug 12, 2022

BUY
$1.34 - $5.34 $62,063 - $247,327
46,316 Added 6.49%
760,466 $1.58 Million
Q1 2022

May 13, 2022

SELL
$4.58 - $6.8 $138,054 - $204,972
-30,143 Reduced 4.05%
714,150 $3.27 Million
Q4 2021

Feb 08, 2022

SELL
$5.23 - $7.18 $554,897 - $761,790
-106,099 Reduced 12.48%
744,293 $4.79 Million
Q3 2021

Nov 15, 2021

SELL
$5.94 - $8.75 $251,630 - $370,667
-42,362 Reduced 4.75%
850,392 $5.26 Million
Q2 2021

Aug 13, 2021

BUY
$7.54 - $9.79 $2.09 Million - $2.71 Million
276,795 Added 44.94%
892,754 $7.14 Million
Q1 2021

May 12, 2021

BUY
$4.76 - $11.25 $434,616 - $1.03 Million
91,306 Added 17.4%
615,959 $5.94 Million
Q4 2020

Feb 11, 2021

SELL
$2.43 - $5.42 $26,914 - $60,031
-11,076 Reduced 2.07%
524,653 $2.53 Million
Q3 2020

Nov 16, 2020

SELL
$2.3 - $3.72 $52,564 - $85,016
-22,854 Reduced 4.09%
535,729 $1.33 Million
Q2 2020

Aug 14, 2020

BUY
$1.33 - $3.63 $17,746 - $48,435
13,343 Added 2.45%
558,583 $1.73 Million
Q1 2020

May 14, 2020

BUY
$1.27 - $2.33 $60,239 - $110,518
47,433 Added 9.53%
545,240 $785,000
Q4 2019

Feb 14, 2020

SELL
$1.3 - $2.72 $52,587 - $110,029
-40,452 Reduced 7.52%
497,807 $1.01 Million
Q3 2019

Nov 13, 2019

BUY
$1.93 - $4.21 $58,563 - $127,748
30,344 Added 5.97%
538,259 $1.27 Million
Q2 2019

Aug 13, 2019

BUY
$2.05 - $4.32 $1,576 - $3,322
769 Added 0.15%
507,915 $2.19 Million
Q1 2019

May 13, 2019

BUY
$1.79 - $3.12 $18,902 - $32,947
10,560 Added 2.13%
507,146 $1.07 Million
Q4 2018

Feb 12, 2019

SELL
$2.24 - $3.9 $2,761 - $4,808
-1,233 Reduced 0.25%
496,586 $1.28 Million
Q3 2018

Nov 14, 2018

BUY
$3.58 - $4.9 $20,645 - $28,258
5,767 Added 1.17%
497,819 $1.94 Million
Q2 2018

Aug 14, 2018

SELL
$4.43 - $5.14 $60,252 - $69,909
-13,601 Reduced 2.69%
492,052 $2.34 Million
Q1 2018

May 09, 2018

BUY
$4.65 - $5.9 $27,941 - $35,453
6,009 Added 1.2%
505,653 $2.63 Million
Q4 2017

Feb 14, 2018

SELL
$4.32 - $5.52 $818,553 - $1.05 Million
-189,480 Reduced 27.5%
499,644 $2.31 Million
Q3 2017

Nov 13, 2017

BUY
$4.35 - $5.25 $3 Million - $3.62 Million
689,124
689,124 $3.62 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.